Browse by author
Lookup NU author(s): Professor Sir John BurnORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Author(s): Dominguez-Valentin M, Haupt S, Seppala TT, Sampson JR, Sunde L, Bernstein I, Jenkins MA, Engel C, Aretz S, Nielsen M, Capella G, Balaguer F, Evans DG, Burn J, Holinski-Feder E, Bertario L, Bonanni B, Lindblom A, Levi Z, Macrae F, Winship I, Plazzer J-P, Sijmons R, Laghi L, Della Valle A, Heinimann K, Debniak T, Fruscio R, Lopez-Koestner F, Alvarez-Valenzuela K, Katz LH, Laish I, Vainer E, Vaccaro C, Carraro DM, Monahan K, Half E, Stakelum A, Winter D, Kennelly R, Gluck N, Sheth H, Abu-Freha N, Greenblatt M, Rossi BM, Bohorquez M, Cavestro GM, Lino-Silva LS, Horisberger K, Tibiletti MG, Nascimento ID, Thomas H, Rossi NT, Apolinario da Silva L, Zarand A, Ruiz-Banobre J, Heuveline V, Mecklin J-P, Pylvanainen K, Renkonen-Sinisalo L, Lepisto A, Peltomaki P, Therkildsen C, Madsen MG, Burgdorf SK, Hopper JL, Win AK, Haile RW, Lindor N, Gallinger S, Le Marchand L, Newcomb PA, Figueiredo J, Buchanan DD, Thibodeau SN, von Knebel Doeberitz M, Loeffler M, Rahner N, Schrock E, Steinke-Lange V, Schmiegel W, Vangala D, Perne C, Huneburg R, Redler S, Buttner R, Weitz J, Pineda M, Duenas N, Vidal JB, Moreira L, Sanchez A, Hovig E, Nakken S, Green K, Lalloo F, Hill J, Crosbie E, Mints M, Goldberg Y, Tjandra D, ten Broeke SW, Kariv R, Rosner G, Advani SH, Thomas L, Shah P, Shah M, Neffa F, Esperon P, Pavicic W, Torrezan GT, Bassaneze T, Martin CA, Moslein G, Moller P
Publication type: Article
Publication status: Published
Journal: eClinicalMedicine
Year: 2023
Volume: 58
Print publication date: 01/04/2023
Online publication date: 20/03/2023
Acceptance date: 27/02/2023
Date deposited: 10/09/2026
ISSN (electronic): 2589-5370
Publisher: Elsevier Ltd
URL: https://doi.org/10.1016/j.eclinm.2023.101909
DOI: 10.1016/j.eclinm.2023.101909
Data Access Statement: The cancer risk algorithm is available at the PLSD website (www.plsd.eu) that is based upon the results presented in this report and enables interactive calculation of remaining lifetime risks for cancer in any patient with LS by giving their age, gender, and gene variant.
Altmetrics provided by Altmetric
